KIMBERLY BRUYERE: Open Payments
NPI 1881626331 · ROGERS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$474 in 25 payments from 13 companies in 2025. Trend: 2023 $651 · 2024 $720 · 2025 $474
Food & beverage: $474
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $59 |
| PFIZER INC. | 3 | $55 |
| AtriCure, Inc. | 2 | $54 |
| Merck Sharp & Dohme LLC | 3 | $46 |
| Novartis Pharmaceuticals Corporation | 3 | $44 |
| Esperion Therapeutics, Inc. | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Novo Nordisk Inc | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 2 | $30 |
| Dexcom, Inc. | 1 | $20 |
Products named: ELIQUIS, VERQUVO, LEQVIO, NEXLETOL, ENROUTE Transcarotid Stent, Kerendia, VYNDAQEL, Wegovy.
Industry payments across AR — which companies pay providers there.
